WallStreetZenWallStreetZen

NASDAQ: PPCB
Propanc Biopharma Inc Stock Ownership - Who owns Propanc Biopharma?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Propanc Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPCB insiders and whales buy or sell their stock.

PPCB Shareholders

What type of owners hold Propanc Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marex Group PLC0.55%70,429$72.54kInstitution
Virtu Financial LLC0.33%41,677$42.93kInstitution
Morgan Stanley0.00%1$1.03Institution

1 of 1

PPCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPCB0.84%0.00%
SNGX0.64%99.36%Net BuyingNet Buying
ICU3.03%37.13%Net BuyingNet Buying
PHIO0.18%99.82%Net BuyingNet Selling
CURX1.03%8.87%
View Top Biotech Stocks

Propanc Biopharma Stock Ownership FAQ

Who owns Propanc Biopharma?

Propanc Biopharma (NASDAQ: PPCB) is owned by 0.84% institutional shareholders, 0.00% Propanc Biopharma insiders, and 99.16% retail investors. Marex Group PLC is the largest individual Propanc Biopharma shareholder, owning 70,429.00 shares representing 0.53% of the company. Marex Group PLC's Propanc Biopharma shares are currently valued at $72.54k.

If you're new to stock investing, here's how to buy Propanc Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.